Remove 2022 Remove Access Remove Compliance Remove Conditions
article thumbnail

Australia: 2022 – 2023 Will Be A Big Year For Medical Cannabis Compliance Says TGA

Cannabis Law Report

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. In addition to the priority areas, the TGA manages many individual compliance activities and investigations. Further compliance priority areas may arise during the year and be added to this list.

article thumbnail

Newly Published Paper: Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act

Cannabis Law Report

Drug Enforcement and Policy Center, August, 2022. 21 Pages Posted: 12 Aug 2022. Date Written: August 11, 2022. But unfortunately, SAFE, as written, is unlikely to result in equitable access to financial services. Promote compliance with state and local regulatory requirements regarding business ownership.

Banking 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Compliance Outfit, Simplifya, To Offer Services in New Mexico

Cannabis Law Report

Simplifya Offers a Suite of Comprehensive Compliance Solutions for Cannabis Businesses in New Mexico Ahead of Adult-Use Sales Launch. Company’s Proven Compliance Solution Helps Cannabis Operators Stay Compliant as State Readies Adult-Use Market. Simplifya Smart Cabinet.

article thumbnail

Paper: “Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act.”

Cannabis Law Report

CRCC’s paper, published by the Ohio State University (OSU) Moritz College of Law, is titled “Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act.”. Drug Enforcement and Policy Center, August, 2022. 21 Pages Posted: 12 Aug 2022. Date Written: August 11, 2022. Cat Packer.

Banking 52
article thumbnail

Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”

Cannabis Law Report

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. 27 September 2022. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

article thumbnail

Canopy Growth Reports First Quarter Fiscal 2022 Financial Results – The John Bonham Of Cannabis?

Cannabis Law Report

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105
article thumbnail

New York Cannabis: State of the State 2023

Canna Law Blog

With licenses issued and sales starting in 2022, New York got the ball rolling on an actual and legal cannabis industry. Let’s take a look at the noteworthy developments of 2022 and what we expect to see in 2023. Three big developments in 2022 1. More conditional cultivation and processing licenses have been issued since.